Juan A. Pineda

13.4k total citations
299 papers, 6.6k citations indexed

About

Juan A. Pineda is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Juan A. Pineda has authored 299 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Hepatology, 192 papers in Epidemiology and 93 papers in Infectious Diseases. Recurrent topics in Juan A. Pineda's work include Hepatitis C virus research (192 papers), Liver Disease Diagnosis and Treatment (127 papers) and Hepatitis B Virus Studies (87 papers). Juan A. Pineda is often cited by papers focused on Hepatitis C virus research (192 papers), Liver Disease Diagnosis and Treatment (127 papers) and Hepatitis B Virus Studies (87 papers). Juan A. Pineda collaborates with scholars based in Spain, United States and Germany. Juan A. Pineda's co-authors include Juan Macı́as, Antonio Rivero, José Antonio López Mira, Nicolás Merchante, José Ángel García-García, Ángela Camacho, Karin Neukam, Mercedes González‐Serrano, Antonio Rivero‐Juárez and Jesús Gómez‐Mateos and has published in prestigious journals such as The Lancet, The Journal of Immunology and PLoS ONE.

In The Last Decade

Juan A. Pineda

288 papers receiving 6.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan A. Pineda Spain 45 4.0k 4.0k 2.0k 977 648 299 6.6k
Ruy M. Ribeiro United States 51 2.2k 0.6× 3.4k 0.8× 2.4k 1.2× 3.3k 3.3× 1.3k 2.0× 203 8.1k
Julian Schulze zur Wiesch Germany 39 2.3k 0.6× 2.2k 0.5× 1.3k 0.6× 1.0k 1.0× 204 0.3× 198 5.4k
Pierre–Yves Bochud Switzerland 37 1.5k 0.4× 2.9k 0.7× 1.2k 0.6× 176 0.2× 364 0.6× 115 4.8k
D. Neau France 35 708 0.2× 1.2k 0.3× 1.7k 0.8× 1.2k 1.2× 169 0.3× 152 3.2k
Massimo Andreoni Italy 37 748 0.2× 2.0k 0.5× 3.0k 1.5× 1.6k 1.6× 199 0.3× 315 5.3k
Michael A. Polis United States 43 930 0.2× 2.9k 0.7× 3.5k 1.7× 4.3k 4.4× 302 0.5× 143 8.6k
Andrea De Luca Italy 50 888 0.2× 2.7k 0.7× 5.1k 2.6× 4.0k 4.1× 392 0.6× 345 9.5k
Annemarie Berger Germany 35 995 0.2× 1.8k 0.5× 1.7k 0.9× 736 0.8× 129 0.2× 130 3.7k
Christoph Sarrazin Germany 60 10.8k 2.7× 10.4k 2.6× 2.5k 1.3× 364 0.4× 131 0.2× 329 13.8k
Bruno Cacopardo Italy 31 643 0.2× 1.2k 0.3× 779 0.4× 253 0.3× 428 0.7× 171 3.1k

Countries citing papers authored by Juan A. Pineda

Since Specialization
Citations

This map shows the geographic impact of Juan A. Pineda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan A. Pineda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan A. Pineda more than expected).

Fields of papers citing papers by Juan A. Pineda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan A. Pineda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan A. Pineda. The network helps show where Juan A. Pineda may publish in the future.

Co-authorship network of co-authors of Juan A. Pineda

This figure shows the co-authorship network connecting the top 25 collaborators of Juan A. Pineda. A scholar is included among the top collaborators of Juan A. Pineda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan A. Pineda. Juan A. Pineda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bravo, María José, María Eugenia Sáez, Itziar de Rojas, et al.. (2024). The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study). Antiviral Research. 222. 105795–105795. 1 indexed citations
2.
Molina, Esther, et al.. (2024). AI Revolution in Education: What You Need to Know. Washington, DC: World Bank eBooks.
3.
López‐López, Pedro, Mario Frías, Ana Belén Pérez, et al.. (2023). Optimization of the molecular diagnosis of the acute hepatitis E virus infection. Microbial Biotechnology. 16(6). 1325–1332. 7 indexed citations
4.
Fernández‐Fuertes, Marta, Juan Macı́as, Anaïs Corma‐Gómez, et al.. (2023). Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain. Enfermedades infecciosas y microbiologia clinica (English ed ). 42(5). 251–256.
5.
Fernández‐Fuertes, Marta, Juan Macı́as, Anaïs Corma‐Gómez, et al.. (2023). Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain. Enfermedades Infecciosas y Microbiología Clínica. 42(5). 251–256. 1 indexed citations
6.
Rivero‐Juárez, Antonio, Mario Frías, Ana Belén Pérez, et al.. (2022). Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe. Journal of Hepatology. 77(2). 326–331. 81 indexed citations
7.
Macı́as, Juan, Pablo Parra-Membríves, Marta Fernández‐Fuertes, et al.. (2022). Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis. Scientific Reports. 12(1). 21897–21897. 2 indexed citations
8.
Fernández‐Fuertes, Marta, Anaïs Corma‐Gómez, Eva Torres, et al.. (2021). Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic. Transboundary and Emerging Diseases. 69(4). e267–e275. 5 indexed citations
9.
Aguilar-Jiménez, Wbeimar, Wildeman Zapata, Antonio Rivero‐Juárez, et al.. (2019). Genetic associations of the vitamin D and antiviral pathways with natural resistance to HIV-1 infection are influenced by interpopulation variability. Infection Genetics and Evolution. 73. 276–286. 2 indexed citations
10.
Brochado‐Kith, Oscar, Luís Miguel Real, Javier Crespo, et al.. (2019). MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection. Journal of Clinical Medicine. 8(6). 849–849. 9 indexed citations
11.
Castro, Rui, Rafael Granados, Juan Macı́as, et al.. (2018). Impact of interferon‐free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real‐life cohort. Journal of Viral Hepatitis. 25(6). 699–706. 12 indexed citations
12.
Calleja, José Luís, José Luís Calleja, Juan Macı́as, et al.. (2018). Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH). Gastroenterología y Hepatología (English Edition). 41(9). 597–608. 1 indexed citations
13.
Midgard, Håvard, Amanda Weir, Norah Palmateer, et al.. (2016). HCV epidemiology in high-risk groups and the risk of reinfection. Journal of Hepatology. 65(1). S33–S45. 125 indexed citations
14.
Aguilar-Jiménez, Wbeimar, Wildeman Zapata, Antonio Carúz, et al.. (2014). Variants in Vitamin D Pathway and Antiviral Response Genes Interact to Modulate the Natural Resistance to HIV-1 Infection. AIDS Research and Human Retroviruses. 30(S1). A217–A218. 1 indexed citations
15.
Rallón, Norma, Juan A. Pineda, Vincent Soriano, et al.. (2012). Differences in Virological Response to Peginterferon-α Plus Ribavirin in HIV-Positive Patients Coinfected With HCV Subtypes 1a or 1b. JAIDS Journal of Acquired Immune Deficiency Syndromes. 60(2). 117–123. 11 indexed citations
16.
Rallón, Norma, Judit Morelló, Pablo Labarga, et al.. (2011). Impact of Inosine Triphosphatase Gene Variants on the Risk of Anemia in HIV/Hepatitis C Virus-Coinfected Patients Treated for Chronic Hepatitis C. Clinical Infectious Diseases. 53(12). 1291–1295. 10 indexed citations
17.
Macı́as, Juan, A. Rivero, Pompeyo Viciana, et al.. (2008). Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis. Journal of Antimicrobial Chemotherapy. 63(1). 178–183. 16 indexed citations
18.
García-García, José Ángel, Manuel Romero‐Gómez, J.A. Girón González, et al.. (2006). Incidence of and Factors Associated with Hepatocellular Carcinoma among Hepatitis C Virus and Human Immunodeficiency Virus Coinfected Patients with Decompensated Cirrhosis. AIDS Research and Human Retroviruses. 22(12). 1236–1241. 15 indexed citations
19.
Macı́as, Juan, Mercedes Cruz-Ruiz, José Ángel García-García, et al.. (2005). Relationship between Osteopenia, Free Testosterone, and Vitamin D Metabolite Levels in HIV-Infected Patients with and without Highly Active Antiretroviral Therapy. AIDS Research and Human Retroviruses. 21(11). 915–921. 25 indexed citations
20.
Morillas‐Márquez, Francisco, et al.. (2002). Leishmania infantum (Protozoa, Kinetoplastida): Transmission from Infected Patients to Experimental Animal under Conditions That Simulate Needle-Sharing. Experimental Parasitology. 100(1). 71–74. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026